Systimmune
Developing multi-specific antibodies and antibody-drug conjugates for cancer therapy
Company facts
- Founded
- 2014
- Employees
- 104
- Headquarters
- United States
- Type
- Private
- Funding
- Corporate Round · $800M · 2023
Developing multi-specific antibodies and antibody-drug conjugates for cancer therapy
Company facts